QUOTED. US FDA.
The number of PMA and 510(k) applications have been steadily growing and becoming harder to review as they’ve become more complex. See what this means, according to an US FDA official, here.
"COVID has had its effect but there were strains on the [US FDA review] system from beforehand because we have seen the complexity of 510(k)s continue to increase." – FDA Official
Click here for a free trial of Medtech Insight